Skip over navigation
Directory
Directory Search
Jobs
Job Search
Post a Job
Patient
Patient Resources
Drug Development
History
Genealogy
Toons & Teasers
About
Advertising
Home
Quick Links
Directory
Job Search
Toons & Teasers
Advertising
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Industry News
Search Articles:
Lilly's Taltz® (ixekizumab) demonstrated no progression or minimal progression with PsA
Eli Lilly announced the majority of patients with active psoriatic arthritis treated with Taltz® (ixekizumab) exhibited either no progression or minimal progression of radiographic structural joint damage through 52 weeks of treatment.
June 16, 2017
More...
Email This Page
to a Friend
Print This
Page